-+ 0.00%
-+ 0.00%
-+ 0.00%
Newbury Pharmaceuticals to Upsize, Extend Maturity of Existing Loan
Share
Listen to the news
12:54 AM EST, 11/19/2026 (MT Newswires) -- Newbury Pharmaceuticals (NEWBRY.ST) agreed with its lender, Slädens Pensionsstiftelse nr 3, to upsize and extend the maturity of its 30 million-krona loan. The loan amount will be increased to 40 million kronor, and maturity will be extended to June 30, 2028, from June 30, 2027, according to a Wednesday release. The annual interest rate will remain unchanged at 11%, payable quarterly. The revised terms also allows the Swedish pharmaceutical company to fully or partially repay the loan early on 30-day notice and without any prepayment fee. The amended agreement is subject to approval at an annual general meeting scheduled on Jan. 20, 2027.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending